Keith J. Christensen, PharmD, BCPS
Keith J. Christensen, PharmD, BCPS

Keith J. Christensen, PharmD, BCPS

Associate Professor
School of Pharmacy and Health Professions

Academic Appointments

Department

  • Pharmacy Practice

Position

  • Associate Professor

Secondary Appointment

  • School of Medicine

Education

  • University of Iowa,B.S.,1988-1990
  • Creighton University,Pharm.D.,1990-1994

Publications and Presentations

Books

  • Christensen KJ. Chapter 66 - Medical Drugs and Their Effect on Sleep and Wakefulness. In Lee-Chiong TL, Sateia MJ, Carskadon MA (eds): Sleep Medicine. Philadelphia, Hanley & Belfus, Journal of Doctoral Nursing Practice, 2001

Articles

  • Brown, Jack E., Fominaya, Cory, Christensen, Keith J., McConnell, Scott A., Lamp, Kenneth C. Daptomycin Experience in Critical Care Patients: Results from a Registry, Annals of Pharmacotherapy, 46, 495-502, 2012
  • Brown J, Cory F, Christensen KJ, McConnell SA, Lamp KC. Daptomycin Experience in Critical Care Patients: Results from a Registry., Annals of Pharmacotherapy, 46, 495-502, 2012
  • Destache, C. J., Belgum, T., Christensen, K., Shibata, A., Sharma, A., Dash, A. Combination antiretroviral drugs in PLGA nanoparticle for HIV-1, BMC infectious diseases, 9, 198, 2009
  • Destache CJ, Belgum T, Christensen KJ, Shibata A, Sharma A, Dash A. Combination antiretroviral drugs in PLGA nanoparticle for HIV-1., Infectious Diseases, 9, 198-205, 2009
  • Malesker, M. A., Foral, P. A., McPhillips, A. C., Christensen, K. J., Chang, J. A., Hilleman, D. E. An efficiency evaluation of protocols for tight glycemic control in intensive care units, American Journal of Critical Care, 16, 589-598, 2007
  • Malesker MA, Foral PA, Christensen KJ, Hilleman DE. An efficiency evaluation of tight glycemic control protocols in the intensive care unit., American Journal of Critical Care, 16, 589-598, 2007
  • Monaghan MS, Jones RM, Faculty Case Writing Teams (Christensen K). Designing an assessment for an abilities-based curriculum; process reliability of the first two years., American Journal of Pharmaceutical Education, 69(2), Article 19, 2005
  • Christensen KJ. Drotrecogin alfa (activated). UHC/Novation Drug Monograph., Journal of Doctoral Nursing Practice, 2001
  • Christensen KJ. Dexmedetomidine. UHC/Novation Drug Monograph., Journal of Doctoral Nursing Practice, 2000
  • Christensen KJ, Gubbins PO, Gurley BJ, Bowman JL, Buice RG. Relative bioavailability of itraconazole from an extemporaneously prepared suspension and the marketed capsule., American Journal of Hospital Pharmacists, 55, 261-265, 1998
  • Christensen KJ, Gubbins PO. Treatment of vancomycin-resistant staphylococcal infections., Journal of Doctoral Nursing Practice, 30, 228-232, 1996

Publications

  • Christensen KJ, Monaghan MS, Walters RW, Chapman T. Delivery Preference and Student Perception of Lecture Capture Impact In A Doctor of Pharmacy Curriculum., American Journal of Pharmaceutical Education, 77(5), 61, 2013
  • Christensen KJ. Evidence of Potential Deficiency in Longitudinal Learning: Revisiting Pharmacy Calculations., American Journal of Pharmaceutical Education, 77(5), 68, 2013
  • Shafer DW, Christensen KJ, Friedman S. Evaluation of aminoglycoside (gentamicin and tobramycin) use, dosing method, and monitoring in an academic medical center versus a private institution., ASHP Midyear Clinical Meeting, 7, 125, 2012
  • Christensen KJ, Pick AM. Utilization of pharmacy residents as pharmacotherapeutics case study coordinators., American Journal of Pharmaceutical Education, 74(5), 96, 2010
  • Anthone JA, Christensen KJ. Changes in heart rate following multiple-dose therapy with inhaled beta-2 agonists in hospitalized patients., ASHP Midyear Clinical Meeting, 44, 2009
  • Elsasser GN, Christensen KJ, Spangler M, Clark B, Davis R, Young WW. Facilitating distance student participation on a pharmacy admission committee via web-cam technology., American Journal of Pharmaceutical Education, 73(4), 57, 2009
  • Christensen KJ, Malesker MA, Ryan-Haddad AM, Poepping-Faulkner MA, Hoie EB. Enhancing therapeutics case study student performance following lab restructure., American Journal of Pharmaceutical Education, 73(4), 57, 2009
  • McConnell SA, Christensen KJ, Patel H, White P. Daptomycin use in critically ill patients with sepsis and MRSA bacteremia., Critical Care Medicine, 37(12), 857, 2009
  • 11. Destache C, Belgum T, Elsasser G, Christensen K, Shibata A. Ritonavir-, Lopinavir-, and Efavirenz-containing Nanoparticles: in vitro release of ART. CROI 2008 – 15th Conference on Retroviruses and Opportunistic Infections, Conference on Retroviruses and Opportunistic Infections, 743, 2008
  • Christensen KJ, McConnell SA, Lamp KC, Brown J. Daptomycin use in critical care patients with sepsis., Critical Care Medicine, 36(12), 618, 2008
  • Christensen KJ, McConnell SA, Brown J, Lamp KC. Daptomycin use in patients with sepsis., Pharmacotherapy, 28, 151e, 2008
  • Foral PA, Malesker MA, Hilleman DE, Christensen KJ, McPhillips A. Nursing satisfaction survey concerning tight glycemic control protocols in the ICU. ASHP Midyear Clinical Meeting, ASHP Midyear Clinical Meeting, 42, 2007
  • Malesker MA, Chang JA, Foral PA, Hilleman DE, Christensen KJ. Analysis of variations in a tight glycemic control protocol. ASHP Midyear Clinical Meeting, ASHP Midyear Clinical Meeting, 41, 2006
  • McConnell SA, Amsden JR, Christensen KJ. 2004 ACCP-Amgen Hematology/Oncology Investigators Development Research Award: Melphalan toxicity and genetic polymorphisms., Pharmacotherapy, 26, e114, 2006
  • Foral PA, Malesker MA, McPhillips AC, Christensen KJ, Hilleman DE. A time-motion analysis of tight glycemic control protocols in the intensive care unit., Pharmacotherapy, 26, e58, 2006
  • Christensen KJ, Boyd ST. Utilizing PDA technology to assess student-patient encounters., American Journal of Pharmaceutical Education, 70(3), 65, 2006
  • Christensen KJ, Ineck BA. Veteran compliance with formoterol therapy. ASHP Midyear Clinical Meeting, ASHP Midyear Clinical Meeting, 40, P-387R, 2005
  • Christensen KJ, Monaghan MS. Evidence of potential deficiency in longitudinal learning: Pharmacy calculations., American Journal of Pharmaceutical Education, 67(3), 100, 2003
  • Stowe CD, Gardner SF, Christensen KJ. Standardized patient examination scores are useful in identifying students most in need of remediation., American Journal of Pharmaceutical Education, 66, 94s, 2002
  • Williams Y, Christensen KJ. Retrospective analysis characterizing the pharmacokinetic monitoring of outpatient aminoglycoside therapy in a cystic fibrosis population. ASHP Midyear Clinical Meeting, ASHP Midyear Clinical Meeting, 36, P-46R, 2001
  • Thomas M, Christensen KJ, Warmack TS, McConnell SA. Retrospective review of community-acquired pneumonia patients receiving warfarin: focusing on changes in INR. ASHP Midyear Clinical Meeting, ASHP Midyear Clinical Meeting, 36, p-266r, 2001
  • Christensen KJ. Impact of a growing cystic fibrosis population on antibiotic sensitivities for Pseudomonas aeruginosa., ASHP Midyear Clinical Meeting, 35, P-428R, 2000

Presentations

  • Asthma Management: Pharmacological Therapy. Asthma Educator Institute (CE PROGRAM), Omaha, NE, July 2014., 2014
  • Development of an Interactive Electronic Health Record as a Training Tool for Pharmacy Students. Wide-River TEC Conference (CE PROGRAM), Lincoln, NE, September 2011., 2011
  • Exam Writing Seminar; Creighton University School of Pharmacy and Health Professions, January, 2010., 2010
  • The Rules of Engagement. Creighton University School of Pharmacy and health Professions School Retreat, January 2010., 2010
  • Christensen KJ. Teaching with technology: A pharmacy resident certificate program. 110th Annual Meeting of the American Association of Colleges of Pharmacy, Boston, MA; July 2009., 2009
  • Exam Writing Seminar; Creighton University School of Pharmacy and Health Professions, January, 2009., 2009
  • Updated Strategies for Asthma Treatment; Creighton University School of Pharmacy and Health Professions Alumni Weekend, October 2008. (CE PROGRAM), 2008
  • Updated Strategies for Asthma Treatment; Midwest College of Clinical Pharmacy Winter Meeting, November 2008. (CE PROGRAM), 2008
  • Update on Pulmonary Hypertension Treatment. VA Pharmacy Grand Rounds Presentation, VA-NWI Medical Center, October 2007. (CE PROGRAM), 2007
  • Liver Failure & Drugs. Department of Internal Medicine – GI Division, Creighton University Medical Center, Omaha, NE. March 2005., 2005
  • Primary Pulmonary Hypertension Review. Department of Pharmacy Practice Grand Rounds, October 2004. (CE PROGRAM), 2004
  • Christensen KJ, Monaghan MS. Evidence of potential deficiency in longitudinal learning: pharmacy calculations. 104th Annual Meeting of the American Association of Colleges of Pharmacy, Minneapolis, MN; July 2003. (Poster presentation), 2003
  • Severe Sepsis Diagnosis & Treatment. Hot Springs Physician and Pharmacist Group, Hot Springs, AR, February 2002., 2002
  • Treatment of Sepsis with Drotrecogin Alfa; Beaumont Oncology/CCN Nurse Group, Beaumont, TX, January 2002, 2002
  • Treatment of Sepsis with Drotrecogin Alfa; Beaumont Pharmacist and Nurse Group, Beaumont, TX, December 2001, 2001
  • Treatment of Sepsis with Drotrecogin Alfa; Northeast Louisiana Association of Health-System Pharmacists, Monroe, LA, November 2001., 2001
  • New Insights on the Treatment of Sepsis; Pine Bluff Pharmacist and Physician Group, Pine Bluff, AR, November 2001, 2001
  • New Insights on the Treatment of Sepsis; Lake Charles Pharmacy Group, Lake Charles, LA, November 2001, 2001
  • New Insights on the Treatment of Sepsis; Southern Region Critical Care Nurses Association, Lafayette, LA, October 2001, 2001
  • Update on Sepsis Treatment. Little Rock Pharmacist Group, Little Rock, AR, September 2001. (CE PROGRAM), 2001
  • New Insights on the Treatment of Sepsis; Arkansas Association of Critical Care Nurses, Little Rock, AR, August 2001. (CE PROGRAM), 2001
  • New Insights on the Treatment of Sepsis; Mid-South College of Clinical Pharmacy, Little Rock, AR, June 2001. (CE PROGRAM), 2001
  • Christensen KJ. Impact of a growing cystic fibrosis population on antibiotic sensitivities for pseudomonas aeruginosa. ASHP Midyear Clinical Meeting, Las Vegas, NV; December 2000. (Poster Presentation), 2000
  • CAP & AECB (review). Physician/Pharmacy Grand Rounds, AHEC Northeast, Jonesboro, AR, October 2000. (CE PROGRAM), 2000
  • Christensen KJ, Parr MD, Thannisch RW, Smith CW. Implementing a monitored drug program using physician order entry. Arkansas Association of health Systems Pharmacists Fall Seminar, Eureka Springs, AR; September 2000. (Poster Presentation), 2000
  • Gubbins PO, Christensen KJ, Crouse KL, Hoffman K, Bradsher RW. A prospective surveillance of antibiotic susceptibilities of gram negative isolates from the intensive care units of a university hospital. ACCP Annual Meeting, Orlando, FL; February 1995., 1995
  • Christensen KJ, Rospond RM. Correlation between obesity and stage of breast cancer at first diagnosis: A retrospective study. ASHP Midyear Clinical Meeting, Atlanta, GA; December 1993. (Poster Presentation), 1993

Research and Scholarship

Grant Funding Received

  • “Retrospective Investigation of the Comparative Effectiveness of Daptomycin vs Vancomycin for the Treatment of MRSA Bacteremia with Vancomycin MICs of 1.5 – 2.0 µg/mL (MASS).” Cubist Pharmaceuticals, Inc., $10,250, funded, Investigator, October 2011 to April 2013.
  • “Development of an Interactive Electronic Health Record as a Training Tool for Pharmacy Students.” Wide River TEC EHR Curriculum Development Award, $3,000, funded, Co-Investigator, February 2011 to December 2011.
  • “Use of a Simulated Electronic Medical Record in Pharmacotherapeutics Case Study.” 2007 Innovations Grant Program, Creighton University, $3,450, funded, Co-investigator, November 1, 2007 to May 31, 2008.
  • “Insulin Infusion Protocols in the ICU: An Efficiency Evaluation.” LifeScan, $50,940 ($11,250 Stipend), Funded, Co-investigator, December 1, 2005 to March 31, 2006.
  • Utilizing PDA Technology to Assess Student-Patient Encounters. 2004 Summer Assessment Grant Program, Creighton University, $6,846.00, Funded, Co-investigator, January 1, 2004 to December 31, 2004.
  • “Evaluation of Aminoglycoside Use, Dosing Method, and Monitoring in an Academic medical Center Versus a Private Institution.” Co-Investigator, 2012 to 2013.
  • “Changes In Heart Rate Following Multiple-Dose Therapy With Inhaled Beta-2 Agonists In Hospitalized Patients.” Co-investigator, 2008 to 2009.
  • “Veteran Compliance with the Formoterol Inhaler.” Co-investigator, 2004 to 2005.

Awards and Honors

  • "Teacher of the Year" March 2011, 2011
  • "Excellence in Leadership Award" November 2009, 2009
  • "Excellence in Teaching Award" February 2009, 2009
  • "Excellence in Leadership Award" October 2007, 2007
  • "Teacher of the Year" March 2007, 2007
  • "Teacher of the Year" April 2006, 2006
  • "Excellence in Teaching Award" February 2006, 2006
  • "Excellence in Leadership Award" October 2005, 2005
  • "Hospital Pharmacist Manager of the Year" October 1998, 1998